References
- Fisch P, Handgretinger R, Schaefer H. Pure red cell aplasia. Br J Haematol 2000; 111: 1010–1022.
- Young NS, Abkowitz JL, Luzatto L. New insights into the pathophysiology of acquired cytopenias. Hematology Am Soc Hematol Educ Program 2000; 18–38.
- D'Andrea AD, Dahl N, Guinan EC, Shimamura A. Marrow failure. Hematology Am Soc Hematol Educ Program 2002; 58–72.
- Sawada K, Hirokawa M, Fujishima N et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica 2007; 92: 1021–1028.
- Kwong YL, Wong KF, Liang RH, Chu YC, Chan LC, Chan TK. Pure red cell aplasia: clinical features and treatment results in 16 cases. Ann Hematol 1996; 72: 137–134
- Srinivas U, Mahapatra M, Saxena R, Pati HP. Thirty-nine cases of pure red cell aplasia: a single center experience from India. Hematology 2007; 12: 245–248.
- Park JH, Spitzer T, Kuter DJ. Successful treatment of pure red cell aplasia with autologous stem transplantation. Am J Hematol 2007; 82: 812–814.
- Lippman SM, Dune BG, Garewal HS, Giordano G, Greenberg BR. Efficacy of danazol in pure red cell aplasia. Am J Hematol 1986; 23: 373–379.